MEDP
|
Medpace Holdings, Inc.
|
0.07%
|
US
|
NASDAQ
|
GMED
|
Globus Medical, Inc.
|
0.07%
|
US
|
NYSE
|
ARWR
|
Arrowhead Research Corporation
|
0.07%
|
US
|
NASDAQ
|
TNDM
|
Tandem Diabetes Care, Inc.
|
0.06%
|
US
|
NASDAQ
|
STAA
|
STAAR Surgical Company
|
0.06%
|
US
|
NASDAQ
|
RARE
|
Ultragenyx Pharmaceutical Inc.
|
0.06%
|
US
|
NASDAQ
|
NTRA
|
Natera, Inc.
|
0.06%
|
US
|
NASDAQ
|
IART
|
Integra LifeSciences Holdings Corporation
|
0.06%
|
US
|
NASDAQ
|
DOCS
|
Doximity, Inc.
|
0.06%
|
US
|
NYSE
|
AMED
|
Amedisys Inc
|
0.06%
|
US
|
NASDAQ
|
ALKS
|
Alkermes plc
|
0.06%
|
US
|
NASDAQ
|
TXG
|
10x Genomics, Inc.
|
0.06%
|
US
|
NASDAQ
|
OSH
|
Oak Street Health, Inc.
|
0.06%
|
US
|
NYSE
|
MRTX
|
Mirati Therapeutics, Inc.
|
0.05%
|
US
|
NASDAQ
|
ICUI
|
ICU Medical, Inc.
|
0.05%
|
US
|
NASDAQ
|
DNLI
|
Denali Therapeutics Inc.
|
0.05%
|
US
|
NASDAQ
|
BPMC
|
Blueprint Medicines Corporation
|
0.05%
|
US
|
NASDAQ
|
RCM
|
R1 RCM Inc.
|
0.05%
|
US
|
NASDAQ
|
HAE
|
Haemonetics Corporation
|
0.05%
|
US
|
NYSE
|
TWST
|
Twist Bioscience Corporation
|
0.04%
|
US
|
NASDAQ
|